|
Winfield, IL - An Edge in the Race to Save Brain Tissue
Central DuPage Hospital (CDH) is the only Illinois hospital that will participate in a national treatment window from 3 hours to 24 hours.
CDH is one of six hospitals in the U.S. making the research trial available to acute ischemic stroke patients. The investigational device is designed to bring oxygen to stroke-damaged areas of the brain by using electrical stimulation of an implant placed in a small nervous center behind the nose, the spheno-palatine ganglion, to increase blood flow and bring needed oxygen to damaged areas of the brain.
The trial, Implant for Augmentation of CBF Trial in a 24 hour window or ImpACT-24, is a multicenter, multinational study that launched Oct. 16 and will take place over the next 2 years. The minimally invasive procedure lasts 10-15 minutes and is performed under local anesthesia, much like a dental procedure.
"While the treatment of ischemic strokes has been growing by leaps and bounds in the last decade, this latest treatment would be a huge step forward because it could potentially extend the treatment window to 24 hours. Currently, the treatment window with FDA-approved devices is 8 hours, or with another investigational device available at CDH and a few other centers is 14 hours," said Harish Shownkeen, MD, principle investigator for this research trial, co-medical director of the Stroke and Neurovascular Program and section chief of the Neurosciences Institute at CDH.
|